Enter assignee name

EPO Patents = 6

Trademarks = 3

Forward Citations = 10

Loading Chart...

7 inventors (with patents filed for the assignee):

Petr Kocis (9 out of 9 patents)

Martin Tolar (9 out of 9 patents)

John A Hey (9 out of 9 patents)

4. Jeremy Yu (2 out of 2 patents)

5. Susan Abushakra (1 out of 1 patent)

6. Aidan Power (1 out of 1 patent)

7. Neil William Flanzraich (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 12285400 - Sulfopropanoic acid derivatives for treating neurodegenerative disorders (2025-04-29),

2. 12187668 - Compositions and methods for treating and preventing neurodegenerative disorders (2025-01-07),

3. 12083082 - Methods for treating neurodegenerative disorders (2024-09-10),

4. 12036208 - Methods for treating neurodegenerative disorders (2024-07-16),

5. 11191742 - Methods of treating neurodegenerative disorders in a particular population (2021-12-07),

6. 11077095 - Methods for treating neurodegenerative disorders (2021-08-03),

7. 11053192 - Compositions and methods for treating and preventing neurodegenerative disorders (2021-07-06),

8. 10590070 - Compositions and methods for treating and preventing neurodegenerative disorders (2020-03-17),

9. 10471029 - Methods for treating neurological disorders (2019-11-12),

Alzheon, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative medicines for patients suffering from neurodegenerative diseases, including Alzheimer's disease. The company's lead product candidate, ALZ-801, is in development as a potential treatment for early and mild Alzheimer's disease. Alzheon's mission is to deliver new treatment options that target the underlying pathology of neurodegenerative diseases to improve the lives of patients and their families.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

9 Patents

#26 in Framingham, MA

#1,867 in Massachusetts

#31,659 in US

Framingham, MA, United States of America

Alzheon, Inc.